EVFM - Evofem Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Evofem Biosciences's activity chart (see below) currently has 52 price targets and 36 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 4.91% of the time, taking 21.25 days on average.

Most recent stock forecast was given by ANNABEL SAMIMY from STIFEL on 12-Oct-2022. First documented stock forecast 14-Dec-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Oct-2020

$2.5

$6000

4 years 1 months 9 days ago
(12-Oct-2022)

1/4 (25%)

$-9.63 (-79.39%)

149

Buy Since 19-Mar-2018

$3750

4 years 3 months 6 days ago
(15-Aug-2022)

0/9 (0%)

$2698.12 (256.50%)

Sell Since 15-Nov-2021

$250

4 years 4 months 6 days ago
(15-Jul-2022)

1/7 (14.29%)

$116.25 (86.92%)

21

Buy Since 08-Jun-2020

$250

$3750

4 years 5 months 27 days ago
(25-May-2022)

0/4 (0%)

$205 (455.56%)

Buy Since 18-Jun-2018

$33750

$46874.98

6 years 3 months 11 days ago
(10-Aug-2020)

0/5 (0%)

$28031.25 (490.16%)

Show more analysts

Please expand the browser size to see the chart

What is EVFM (Evofem Biosciences) average time for price targets to be met?

On average it took 21 days for the stock forecasts to be reached, with an average price target met ratio of 4.91%.

Which analyst most recently updated their price target on EVFM (Evofem Biosciences)?

Annabel Samimy

Which analyst has the lowest performance score on EVFM (Evofem Biosciences) with a proven track record?

RANDALL STANICKY

Which analyst has the most public recommendations on EVFM (Evofem Biosciences)?

Annabel Samimy works at STIFEL and has 5 price targets and 5 ratings on EVFM

Which analyst is the currently most bullish on EVFM (Evofem Biosciences)?

Leland Gershell with the highest potential upside of $33749

Which analyst is the currently most reserved on EVFM (Evofem Biosciences)?

Jeffrey Hung with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?